跳轉至內容
Merck
  • Hurler disease bone marrow stromal cells exhibit altered ability to support osteoclast formation.

Hurler disease bone marrow stromal cells exhibit altered ability to support osteoclast formation.

Stem cells and development (2012-01-28)
Francesca Gatto, Daniela Redaelli, Agnese Salvadè, Simona Marzorati, Benedetto Sacchetti, Chiara Ferina, Valerie D Roobrouck, Francesca Bertola, Michela Romano, Guglielmo Villani, Laura Antolini, Attilio Rovelli, Catherine M Verfaillie, Andrea Biondi, Mara Riminucci, Paolo Bianco, Marta Serafini
摘要

Mucopolysaccharidosis type I (MPS IH; Hurler syndrome) is a rare genetic disorder that is caused by mutations in the α-L-iduronidase (IDUA) gene, resulting in the deficiency of IDUA enzyme activity and intra-cellular accumulation of glycosaminoglycans. A characteristic skeletal phenotype is one of the many clinical manifestations in Hurler disease. Since the mechanism(s) underlying these skeletal defects are not completely understood, and bone and cartilage are mesenchymal lineages, we focused on the characterization of mesenchymal cells isolated from the bone marrow (BM) of 5 Hurler patients. IDUA-mutated BM stromal cells (BMSC) derived from MPS IH patients exhibited decreased IDUA activity, consistent with the disease genotype. The expansion rate, phenotype, telomerase activity, and differentiation capacity toward adipocytes, osteoblasts, chondrocytes, and smooth muscle cells in vitro of the MPS I BMSC lines were similar to those of BMSC from age-matched normal control donors. MPS I BMSC also had a similar in vivo osteogenic capacity as normal BMSC. However, MPS I BMSC displayed an increased capacity to support osteoclastogenesis, which may correlate with the up-regulation of the RANKL/RANK/OPG molecular pathway in MPS I BMSC compared with normal BMSC.

材料
產品編號
品牌
產品描述

Sigma-Aldrich
α- L -艾杜糖醛酸酶 人, recombinant, expressed in mouse NSO cells